Tags

Type your tag names separated by a space and hit enter

[Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem].
Ter Arkh. 2019 Aug 15; 91(8):135-140.TA

Abstract

From the standpoint of evidence - based medicine, the ability of various drugs to induce the development of gastroesophageal reflux disease and esophagitis is considered. Thus, all known drugs can be divided into 3 groups: drugs that have the ability to reduce pressure in the lower esophageal sphincter, for example, β-adrenoreceptor agonists, α-adrenoreceptor antagonists, anticholinergics, calcium channel blockers, nitrates, benzodiazepines (diazepam), estrogen, progesterone, aminophylline (theophylline), tricyclic antidepressants, selective serotonin reuptake inhibitors, glucocorticosteroids; means providing a direct damaging effect on the esophageal mucosa, as well as lowering its resistance reflyuktatu, e.g., bisphosphonates, acetylsalicylic acid / non - steroidal anti - inflammatory agents, anticoagulants, antiplatelet drugs, iron preparations, ascorbic acid, potassium chloride, quinidine, phenytoin, calcium dobesilate, 131I sodium iodide, antibiotics (tetracycline, doxycycline, clindamycin, ciprofloxacin, ornidazole, clindamycin, rifampicin), antitumor agents; drugs that impede gastric emptying: calcium channel blockers, anticholinergics. These data can be used in practice in the choice of treatment tactics, especially in individuals with a diagnosis of gastroesophageal reflux disease or heartburn.

Authors+Show Affiliations

Samara State Medical University.Samara State Medical University.Samara State Medical University.Sechenov First Moscow State Medical University (Sechenov University).

Pub Type(s)

Journal Article

Language

rus

PubMed ID

32598765

Citation

Osadchuk, A M., et al. "[Gastroesophageal Reflux Disease and Esophagitis Associated With the Use of Drugs: the Modern State of the Problem]." Terapevticheskii Arkhiv, vol. 91, no. 8, 2019, pp. 135-140.
Osadchuk AM, Davydkin IL, Gricenko TA, et al. [Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem]. Ter Arkh. 2019;91(8):135-140.
Osadchuk, A. M., Davydkin, I. L., Gricenko, T. A., & Osadchuk, M. A. (2019). [Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem]. Terapevticheskii Arkhiv, 91(8), 135-140. https://doi.org/10.26442/00403660.2019.08.000228
Osadchuk AM, et al. [Gastroesophageal Reflux Disease and Esophagitis Associated With the Use of Drugs: the Modern State of the Problem]. Ter Arkh. 2019 Aug 15;91(8):135-140. PubMed PMID: 32598765.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem]. AU - Osadchuk,A M, AU - Davydkin,I L, AU - Gricenko,T A, AU - Osadchuk,M A, Y1 - 2019/08/15/ PY - 2020/04/16/received PY - 2020/6/30/entrez PY - 2020/7/1/pubmed PY - 2020/7/30/medline KW - antidepressants KW - contraceptive drugs KW - cytostatics KW - glucocorticosteroids KW - medical reflux esophagitis KW - nonsteroidal anti-inflammatory drugs SP - 135 EP - 140 JF - Terapevticheskii arkhiv JO - Ter. Arkh. VL - 91 IS - 8 N2 - From the standpoint of evidence - based medicine, the ability of various drugs to induce the development of gastroesophageal reflux disease and esophagitis is considered. Thus, all known drugs can be divided into 3 groups: drugs that have the ability to reduce pressure in the lower esophageal sphincter, for example, β-adrenoreceptor agonists, α-adrenoreceptor antagonists, anticholinergics, calcium channel blockers, nitrates, benzodiazepines (diazepam), estrogen, progesterone, aminophylline (theophylline), tricyclic antidepressants, selective serotonin reuptake inhibitors, glucocorticosteroids; means providing a direct damaging effect on the esophageal mucosa, as well as lowering its resistance reflyuktatu, e.g., bisphosphonates, acetylsalicylic acid / non - steroidal anti - inflammatory agents, anticoagulants, antiplatelet drugs, iron preparations, ascorbic acid, potassium chloride, quinidine, phenytoin, calcium dobesilate, 131I sodium iodide, antibiotics (tetracycline, doxycycline, clindamycin, ciprofloxacin, ornidazole, clindamycin, rifampicin), antitumor agents; drugs that impede gastric emptying: calcium channel blockers, anticholinergics. These data can be used in practice in the choice of treatment tactics, especially in individuals with a diagnosis of gastroesophageal reflux disease or heartburn. SN - 0040-3660 UR - https://www.unboundmedicine.com/medline/citation/32598765/[Gastroesophageal_reflux_disease_and_esophagitis_associated_with_the_use_of_drugs:_the_modern_state_of_the_problem] L2 - http://www.diseaseinfosearch.org/result/2996 DB - PRIME DP - Unbound Medicine ER -